Best Grants for Cancer Nonprofits in Montana

Nonprofit 501(c)(3) organizations and K–12 schools in Montana working on cancer research, health services, or related human services can apply for grants from the Albertsons Companies Foundation. Programs that expand access to cancer trials, preventive testing, treatment, or supportive care for local residents may be eligible.

Montana nonprofit organizations providing direct services in education, health and human services, arts and culture, or community service can access funding through the Dennis & Phyllis Washington Foundation to support disadvantaged individuals and families. Cancer-focused nonprofits may be eligible if their programs fit these areas and primarily serve low-income, rural, or underserved populations with measurable impact.

This initiative aims to support research interventions targeting disparities in liver diseases and liver cancer among underserved populations in the U.S. It encourages innovative approaches to reduce health inequities and improve health outcomes. The funding opportunity is available through various deadlines for both standard and renewal applications, promoting multi-level strategies to address these critical health issues effectively.

Cancer research organizations and healthcare institutions in Montana can apply for up to US $13,000,000 to conduct patient-centered comparative clinical effectiveness research across the cancer care continuum. With a mission to improve healthcare decisions, Patient-Centered Outcomes Research Institute supports researcher–community partnerships that address screening barriers, treatment delivery, and survivorship needs for U.S. patients and caregivers.

Montana cancer and health research organizations conducting retrospective observational comparative effectiveness studies can access funding through the Patient-Centered Outcomes Research Institute. Projects must use existing data sources and address at least one approved topic, such as cancer, pain, substance use, maternal morbidity and mortality, intellectual and developmental disabilities, sensory health, metabolic and endocrine health, mental and behavioral health, or rare diseases, with awards up to US $2,000,000.

Cancer research institutions and translational research centers in Montana and other U.S. jurisdictions can seek funding to develop organ-specific or biologically related cancer SPORE programs. National Institutes of Health P50 center grants support state-of-the-art translational projects aimed at improving prevention, early detection, diagnosis, and treatment of human cancers, including cross-cutting themes like pediatric cancers or epigenetics.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. The Heart of Illinois Community Foundation scholarship may benefit Montana cancer nonprofits whose staff or beneficiaries have ties to these Illinois regions.

Full-time radiation oncology faculty clinicians conducting cancer research in Montana can seek career development support through the ASTRO-ACS Clinician Scientist Development Grant, receiving US $135,000 annually for 3–5 years. Focused on cancer/oncology, this program from the American Society for Radiation Oncology and the American Cancer Society helps clinicians become independent clinician scientists.

Practicing radiation oncologists conducting cancer research in the U.S., including Montana, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years. This American Society for Radiation Oncology partnership supports clinician-scientists studying questions across the cancer care continuum.

Montana cancer and healthcare organizations, including hospitals, medical schools, patient advocacy groups, and eligible 501(c)(3) nonprofits, can access funding through Incyte for programs focused on healthcare information and patient care. Support may cover cancer and other disease-related education, nursing, and professional training that improve the lives of patients and caregivers.

Cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible nonprofits in Montana can seek funding for healthcare information initiatives, education, and patient support. Focused on improving the lives of patients with cancer and other diseases, Incyte invites healthcare-related charitable contribution, sponsorship, and membership requests that align with its compliance and regulatory guidelines.

The 2026 Radiation Oncology Institute- Innovation Awards aim to advance cancer treatment by integrating radiation therapy with immunotherapy. Researchers are invited to submit proposals that explore optimal combinations of these modalities to enhance patient outcomes. Funding of up to $100,000 over two years will support projects focused on identifying effective treatment strategies, understanding mechanisms of synergy, and improving access to care. This initiative represents a significant opportunity for innovative research in oncology.

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

Pfizer is offering a grant opportunity for independent medical education initiatives focused on Muscle Invasive Bladder Cancer (MIBC). This program aims to address the current knowledge gaps among healthcare professionals regarding emerging treatment data and its potential impact on clinical practices. By collaborating with Astellas, Pfizer seeks proposals that enhance awareness and understanding of the evolving MIBC landscape, ultimately improving patient outcomes in this critical area of unmet medical need.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The ASCO Clinical Oncology & Research Experience (ASCO CORE) offers medical students immersive exposure to the field of oncology through shadowing experiences in clinical and research settings. With two distinct tracks, participants can gain insights into patient care or research practices, guided by mentors. Eligible students must be enrolled in a U.S. DO or MD program and maintain a good academic record. This program aims to inspire the next generation of oncology professionals.

Grants Program for Penn Investigators - Faculty Awards

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Faculty Awards

Faculty awards are for two years with a funding level up to $200,000 per year.

Grants Program for Penn Investigators - Early career awards for Fellows, Postdocs and Instructors

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Early career awards for Fellows, Postdocs and Instructors

Early career awards for Fellows, Postdocs and Instructors up to $100,000 for one year. Grants are eligible for competitive renewal upon reapplication and are contingent on progress the first year.

The CORE Funding: AHNS Presidential Award supports innovative research that integrates emerging technologies in head and neck cancer studies. This initiative aims to address critical gaps in early detection and treatment, especially for patients with advanced disease. By leveraging tools such as AI and advanced imaging, the program seeks to enhance understanding of disease mechanisms and improve patient-centered intervention strategies, ultimately advancing the field of otolaryngology.

The CORE Funding: AHNS Thyroid Cancer Survivors’ Association Award aims to support vital research projects focused on thyroid cancer, encompassing prevention, diagnosis, treatment, and outcomes. This initiative by the American Academy of Otolaryngology - Head and Neck Surgery Foundation promotes advancements in the field through funding opportunities that enhance research capabilities and foster collaboration among researchers. Through the support of this award, significant strides can be made in understanding and combating thyroid cancer.

The CORE Funding: AHNS Trainee Pilot Research Award supports innovative research in head and neck oncology, encouraging trainees to engage in clinical or translational studies. Since its inception, CORE has provided over $14 million in grants, facilitating significant advancements in otolaryngology. This initiative aims to enhance research efforts, reduce fragmentation, and promote collaboration among various stakeholders to improve outcomes for patients with head and neck neoplastic diseases.

The CORE Funding: Lilly Research Grant aims to advance research on genetic hearing loss. It invites investigators to explore the genetic factors contributing to hearing loss, promoting innovative projects that enhance understanding in this critical area. Supported by the American Academy of Otolaryngology - Head & Neck Surgery Foundation, the grant fosters significant research efforts to improve outcomes and strategies in otolaryngology, ensuring a comprehensive approach to hearing health.

The National Cancer Institute (NCI) invites applications for the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) program. This funding opportunity focuses on advanced pre-clinical research aimed at developing nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards will support the maturation of innovative nanomedicines using nanoparticles and nano-devices, enhancing cancer treatment efficacy. Successful projects will progress towards further NCI translational programs, such as the NExT initiative.